AtillaErtanMD

Advanced Endoscopic Interventional, Esophagus Disease, Inflammatory Bowel Disease, Pancreas Disease

Professor Emeritus of the University of Texas McGovern Medical School: Former Professor of the GI Division at the University of Texas McGovern Medical School with Founding Chair of the Houston Digestive Health Institute and Founding Director of the Ertan Gastroenterology/Liver Centers of Excellence

Join to view full profile

Dr. Ertan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ertan's full profile

Already have an account?

Office
6400 Fannin St
Ste 1400
Houston, TX 77030
Phone+1 713-704-5928

Fax+1 713-704-9938

Summary

The Ertan Digestive Disease Center/Gastroenterology Center of Excellence comprise a fully integrated program-based model by experienced/academic gastroenterologists and hepatologists aimed at optimizing patient care, postgraduate education and clinical research in all digestive diseases in the Texas Medical Center. The Ertan Center would integrate an academic structure with a prominent private GI practice as a leading referral site in the TMC for complex digestive diseases from local, national and international physicians on a tertiary care basis. Dr. Ertan has a special interest & expertise in the diagnosis and management of patients with inflammatory bowel diseases, including Crohn's disease, ulcerative colitis, microscopic colitides; biliary/pancreatic benign & malignant diseases; Barrett's esophagus with dysplasia and early cancer plus these patients' need for various advanced endoscopic diagnostic/therapeutic modalities. The Ertan Center will also have various subcenters such as; * GERD/Barrett's Esophagus; *Inflammatory Bowel Diseases; * GI Motility & Physiology; *Biliary-Pancreas Disorders; * Advanced GI Diagnostic & Therapeutic Endoscopy; * Bariatric Gastroenterology; * Hepatology; * Gastroenterology & Hepatology Outcomes; *Liver & pancreas transplantation; * Advanced GI, Biliary-Pancreas Surgery.

Education & Training

Penn MedicinePost-Doctoral Fellowship, 1969 - 1971
Gastroenterology Section, University of Ankara, School of MedicineFellowship, 1967 - 1969
University of Ankara, School of MedicineResidency, 1963 - 1967
University of Ankara, School of MedicineMD, 1957 - 1963
Ankara University FOMClass of 1963

Certifications & Licensure

TX State Medical License 1991 - 2024
LA State Medical License 1980 - 2001
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

Atilla Ertan, MD Gastroenterology Advanced Endoscopy Chair [$1 million[ University of Texas McGovern Medical School, 2013
Atilla Ertan Gastroenterology Basic Science Research Chair [$1 million UTMMS, 2023
Atilla Ertan IBD Endowment Chair 2023 [$1 million] UTMMS, 2023
Ertan Research & Education Foundation UTMMS and MHHS, 2014
Ertan-Chao Endowment Chair [$2 million} MHHS, Ertan Digestive Disease Center,, 2018
Atilla Ertan, MD Lectureship University of Texas McGovern Medical School, 2013
Distinguished Gastroenterologist of the Year American Gastroenterological Association, Orlando, FL, 2003
Special Recognition Award of 2003 Crohn’s and Colitis Foundation of America, Houston, TX, 2003
Master in Gastroenterology American College of Gastroenterology, Baltimore, MD, 2003
Turkish American of he Year Assembly of Turkish American Association Washington, DC, 2003
Best Physician Award of 1996 by the Crohn's and Colitis Foundation of America Houston, TX, 1996
Medicine Science Award of 1992 by the Turkish Science and Technology Research Assembly (TUBITAK), Ankara, Turkey, 1993
Honorary citizen of the city of New Orleans (with golden key) New Orleans, LA, 1989
Fellow of the American College of Physicians 1983
Certified (and Medal) for the "Best Researcher of L'Union Medical Balkanique" Bucharest, Romania, 1973
Kamorov Research Award (second place) Philadelphia, PA, 1971
Eczacibasi research award for the best GI fellow in the AUMS (Turkish) 1968
Eczacibasi Research Award for the best medicine resident in the AUMS (Turkish) 1966
Who’s Who in Science 2003-present
Who's Who in America 2004-present
Fellow of the American Gastroenterological Association 2007-present
Marquis Who's Who in Medicine and Healthcare 2002-present
Award of Excellence in Education by Department of Medicine Baylor College of Medicine, Houston, TX, 1996, 1997 & 1998
"Top Doctors List" in the USA 1996-present
International Who's Who of Professionals 1995-present
Excellence in Clinical Teaching" by the Tulane's Medicine Resident Corps Tulane University Medicsl School, New Orleans, LA, 1981, 1983, & 1986
Please see the web site, "atillaertan.com".
Join now to see all

Clinical Trials

Lithotripsy for the Treatment of Gallstones Start of enrollment: 2002 May 01
Terminated
Phase 4

Publications & Presentations

PubMed

Optimal Management of Patients with Moderate-to-Severe Inflammatory Bowel Disease.
Tugrul Purnak, Atilla Ertan
Journal of Clinical Medicine. 2024-11-21
Incomplete Intestinal Metaplasia of the Stomach Is more Related to Bile Reflux than Chronic Gastritis.
Mamoun Younes, Ayush Arora, Andrew W DuPont, Brooks D Cash, Atilla Ertan
Annals of Clinical and Laboratory Science. 2023-09-01
1 citations
Oral small molecule agents in management of ulcerative colitis: fact or fancy?
Benan Kasapoğlu, Atilla Ertan
Turkish Journal of Medical Sciences. 2023-01-01

Journal Articles

Non-steroidal anti-inflammatory drugs and acute upper gastrointestinal bleeding.
Patel R, Mahatma M, Jalfon I, Hammer RA, Ertan A, Agrawal N, Gastroenterology, 98(5)2:A104
Prevention of gastric stress ulceration by misoprostol: Absence of relationship to tumor necrosis factor.
Mahatma M, Nelson S, Hoda SA, Alptekin N, Brown DA, Agrawal N, Ertan A, Gastroenterology 98(5)2:A150
: Distribution of vascular malformations of gastrointestinal tract and associated disorders.
Speth G, Ertan A, Gastroenterology, 98(5)2:A204
Galanin inhibits rat pancreatic exocrine secretion in vivo.
Yagci RV, Alptekin N, Zacharia S, Rossowski WJ, Ertan A, Coy DH, Gastroenterology 98(5)2:A240
The effect of various medications on ethanol-induced gastric injury in rats.
Alptekin RN, Yagci RV, Rossowski WJ, Ertan A, Coy DH. Prolonged in vitro Brown DA, Yagci RV, Mahatma M, Sitton JE, Agrawal N, Ertan A, Gastroenterology 98(5)2:A651
Effect of pituitary adenylate cyclase activating polypeptide (PACAP) on rate pancreatic exocrine secretion.
Mungan Z, Ertan A, Hammer RA, Arimura A, Gastroenterology, 100(5)2:A291
External shock-wave lithotripsy and ursodiol vs ursodiol alone for the treatment of symptomatic gallstones.
Ertan A, Hernandez RE, Campeau RJ, Gashner J, Litwin M, Gastroenterology, 100(5)2:A314
Relaxant effect of pituitary adenylate cyclase activating polypeptide (PACAP) on rat intestinal smooth muscle.
Mungan Z, Rossowski WJ, Ertan A, Coy DH, Arimura A, Gastroenterology, 100(5)2:A474
Distribution of pituitary adenylate cyclase activating polypeptide (PACAP) in the ovine gastrointestinal tract.
Koves K, Vigh S, Ertan A, Arimura A, Gastroenterology, 100(5)2:A650
Inhibitory action of galanin on gastric acid and pancreatic amylase secretions in vivo.
Mills MR, Zacharia S, Mungan Z, Ertan A, Coy DH, Rossowski WJ, Gastroenterology, 100(5)2:A835
Cisapride in the treatment of GERD: a double-blind, placebo-controlled multicenter dose-response trial.
Faruqui S, Sigmund C, Smith R, Fitch D, Mellow M, Orr W, Pruitt R, Ertan A, Gastroenterology 102(4)2:A66
Peripheral and central effects of PACAP-27 on gastric acid secretion in rats.
Mungan Z, Komaki G, Hammer RA, Ertan A, Arimura A, Gastroenterology 102(4)2:A129
Inhibitory effect of PACAP-27 on rat gastrointestinal smooth muscle contractions.
Mungan Z, Arimura A, Ertan A, Rossowski WJ, Coy DH, Gastroenterology 102(4)2:A490
Galanin:effect of new galanin agonists on pancreatic amylase secretion and jejunal smooth muscle contraction.
Rossowski WI, Zacharia S, Mungan Z, Mills M, Ertan A, Coy DH, Gastroenterology 102(4)2:A754
Acute pancreatitis in marathon runners.
Schneider FE, Ertan A, Am J Gastroenterol 8919:583
Alpha-1-antitrypsin deficiency and chronic pancreatitis.
Rabassa A, Schwartz M, Ertan A, Am J Gastroenterol 89(9):520
Barrett's adenocarcinoma and ND: YAG (Neodymium: Yttrium aluminum garnet) laser therapy.
Zimmerman MS, Ertan A, Am J Gastroenterol 89(9):67
The role of enteroscopy in small bowel disease.
Zimmerman MS, Cole RA, Woods KL, Rabassa AA, Ertan A, Gastroint Endosc 41(4):313
Endoscopic management of bile duct injury following cholecystectomy.
Rabassa AA, Cole RA, Ertan A, Anand B, Zimmerman M, Woods KL, Gastroint Endosc 41(4):464
Endoscopic pancreatic stenting (EPS) after endoscopic pancreatic papilla dilation (EPPD) without pancreatic sphincterotomy.
Ertan A, Syed K, Amer J Gastroenterol 90(9):196
Novel tube decompression of colonic acute pseudoobstruction.
Ertan A, Syed K, Woods K, Cole R, Amer J Gastroenterol 90(9)343
Sensitivity and specificity of p53. protein acumulation as a marker of malignant potential in Barrett's metaplasia.
Younes M, Ertan A, Lechago L, Lechago J, Am J Gastroenterol 91: 1901
The efficacy and safety of endoscopic transpapillary drainage of pancreatic pseudocysts (ETDPP) without pancreatic sphincterotomy.
Ertan A, Am J Gastroenterol 91: 1932
Detection of oxidative DNA damage (ODD) in patients with reflux esophagitis (RE) by immunohistochemistry.
Younes M, Santella RM, Ayub K, Younes P, Pathak MHS.M, Ertan A, Am J Gastroenterol 92:1606
Relationship between dysplasia, p53 protein, DNA ploidy, glut1, and Rb protein in Barrett's Metaplasia (BM).
Younes M, Lechago J, Chakraborty S, Ostrowski M, Bridges M, Canales L, Meriano F, Solcher D, Barroso A, Balsaver A, Ertan A, Am J Gastroenterol 92:1607
Join now to see all

Books/Book Chapters

Relationship between dysplasia, p53 protein accumulation, DNA ploidy, and Glut1 overexpression in Barrett metaplasia.
Younes M, Ertan AScandinavian University Press
Proceedings of the First Congress of the Asian and Oceanian Physiological Societies.
Chapter: Somatostatin, corticotropin releasing hormone and growth hormone releasing hormone in gastrointestinal tract.
Page 159 - 166Arimura A, Minamino N, Uehara A, Groot K, Degertekin A, Ozden A, Akdamar k, Rossowski WJ, Hyman M, Coy DH, Ertan AEditors: Pholpramool C, Sudsuang R.
Proceedings of the First Congress of the Asian and Oceanian Physiological Societies.
Chapter: Somatostatin, corticotrophin releasing hormone and growth hormone releasing hormone in gastrointestinal tract
Page 159 - 166Ertan AEditors: Pholpramool C, Sudsuang R.The Physiological Society
Difficult Decisions in Digestive Diseases.
Chapter: Massive rectal bleeding: What is a rational approach
Page 427 - 432Ertan A, N.M. AgrawalEditors: Barkin JS, Rogers AI.Year Book Medical Publishers, Inc.
Gastroenteroloji.
Chapter: Pancreatic physiology; Chronic pancreatitis; Pancreatic tumors; Cystic fibrosis
Page 367 - 389Ertan AEditors: Aktan H.Macro Publishers, Inc., Turkish
Consultant in 12 different chapters in gastroenterology, Board of Consultants.
Chapter: The 5-Minute Clinical Consult (Book and data base).
Ertan AEditors: Griffith HW, Dambro M.Lea & Febiger, Philadelphia and LondonEdition 14,
Current Practice of Medicine, Gastroenterology.
Chapter: Endocrine tumors of gastrointestinal tract
Ertan AEditors: Graham DY, Ertan A.Current Medicine, PhiladelphiaEdition 3,
Gastroenterology and Hepatology - Pearls of Wisdom.
Chapter: Cholelithiasis and Associated Conditions: Gallbladder and Biliary, Gallstone Disease and its Complications.
Page 24 - 37Ertan A Balachandar G., Raijman I., Trowers E.AEditors: DiBaise JK.Boston Medical Publishing Corp
Gastroenterology.
Chapter: Best Practice of Medicine
Ertan AEditors: Gotto A.Praxis Press Inc, Internet base textbook
Gastroenterology and Hepatology Board Review.
Chapter: Medical Aspects of Cholelithiasis
Ertan A, Wolf DEditors: DiBaise JK.The Mc Graw-Hill Comp, Inc, Pearls of WisdomEdition 3,
Join now to see all

Abstracts/Posters

The human erythrocyte glucose transporter glut1 is expressed as a late event during neoplastic progression in Barrett's metaplasia.
Younes M, Ertan A, Lechago LV, Somoano J, Lechago J, The United States and Canadian Academic of Pathology Annual Meeting, Washington DC
p53 protein accumulation is an early indicator of malignant potential in Barrett's metaplasia.
Younes M, Ertan A, Lechago LV, Somoano J, Lechago J, Accepted for publication in the United States and Canadian Academic of Pathology Annual Meeting, Washington DC
Cisapride 20 mg bid provides effective daytime and nighttime relief in patients with symptoms of chronic gastroesophageal reflux disease.
Castell D, Sigmund C, Patterson D, Ertan A, Gastroenterology 112:84
Comparative assessment of biopsy forceps for upper endoscopy: Pathologist blinded randomized study.
Woods, KL, Anand BS, Cole R, Killip DM, Ertan A, Gastrintest Endosc. 102:45
Comparison between brush cytology (Cy) and Biopsy (Bx) in the detection of dysplasia, p53 accumulation, and Glut1 expression in patients with Barrett's Metaplasia (BM).
Younes M, Lechago J, Ertan A, Am J Gastroenterol 92:1606
Profiling colorectal cancer.
Ertan A, Annual report for cancer registry, The Methodist Hospital, 5:18-24
Join now to see all

Lectures

World Congress of Gastroenterology: Chair of the Symposium on GI disorders in elderly.
Invited lecturer on Endoscopic Management of Pancreatitis. Austria Center, Vienna, Austria
Barrett’s Esophagus.
Annual BCM Postgraduate Course, Gastroenterology 2000: Challenges in the New Millennium. Houston, Tx
Long-term results after endoscopic pancreatic stenting without pancreatic papillotomy in acute recurrent pancreatitis due to pancreas divisum.
Annual Meeting at Digestive Disease Week by American Gastroenterological Association. Orlando, FL
Fas-Ligand (FASL) expression in esophageal carcinomas and their nodal metastases.
Annual Meeting at Digestive Disease Week by American Gastroenterological Association. Orlando, FL
The thin prep method is superior to cytospins in preparing cytologic preparations from patients with Barrett’s metaplasia.
Annual American College of Gastroenterology Meeting. Boston, Massachusetts
Expression of Fas (CD95/APO1) in Barrett’s metaplasia, dysplasia and carcinoma.
Annual American College of Gastroenterology Meeting. Boston, Massachusetts
Dysplasia, p53 protein, DNA ploidy, and GLUT1, in Barrett’s metaplasia: preliminary results of prospective study.
Annual American College of Gastroenterology Meeting. Boston, Massachusetts
Neuroendocrine tumors of the Gastrointestinal Tract.
Seminar: International Hospital Istanbul & The Methodist Hospital Houston. Istanbul, Turkey
Surgical Management of inflammatory bowel disease.
Seminar: International Hospital Istanbul & The Methodist Hospital Houston. Istanbul, Turkey
Barrett’s metaplasia: general perspectives.
Postgraduate Course of the Turkish Society of Gastroenterology. Honorary president. Istanbul, Turkey
Photodynamic therapy for GI cancers.
Annual BCM Postgraduate Course, Gastroenterology 2000: Challenges in the New Millennium. Houston, Tx
Biliary acute pancreatitis.
Annual Postgraduate Course of BCM GI Division. Houston, TX
Barrett's esophagus - what is new?
Annual Postgraduate Course of BCM GI Division. Houston, TX
Colo-rectal cancer screening and prevention.
Medical symposium by American Hospital and TMH/BCM-GI program director. Istanbul, Turkey
Barrett's metaplasia.
Medical symposium by American Hospital and TMH/BCM-GI program director. Istanbul, Turkey
Relationship between dysplasia, p53 protein, DNA ploidy, glut 1, and Rb protein in Barrett's metaplasia.
Annual American College of Gastroenterology Meeting. Chicago, IL
Comparison between brush cytology and biopsy in the detection of dysplasia, p53 accumulation, and Glut I expression in patients with Barrett's metaplasia.
Annual American College of Gastroenterology Meeting. Chicago, IL
Detection of oxidative DNA damage in patients with reflux esophagitis by immunohistochemistry.
Annual American College of Gastroenterology Meeting. Chicago, IL
The efficacy of endoscopic transpapillary drainage of pancreatic pseudocysts without pancreatic sphincterotomy.
Annual American College of Gastroenterology Meeting. Seattle, WA
Sensitivity and specificity of P53 protein accumulation as a marker of malignant potential in Barrett's metaplasia.
Annual American College of Gastroenterology Meeting. Seattle, WA
. Prior fundoplication does not improve subsequent safety or efficacy outcomes of radiofrequency ablation (RFA): Results from the US RFA Registry.
American Gastroenterological Association Annual Meeting. San Diego, CA
Predictors of recurrent Barrett’s esophagus after successful radiofrequency ablation in a nationwide, multicenter cohort: Results from the U.S. RFA Registry.
American Gastroenterological Association Annual Meeting. Orlando, FL
Effect of site volume on eradication of Barrett’s esophagus (BE): Results from the U.S. RFA Registry.
American Gastroenterological Association Annual Meeting. Orlando, FL
Predictors of subsquamous intestinal metaplasia (SSIM) in patients with prior radiofrequency ablation (RFA) for treatment of Barrett’s esophagus: Results from the U.S...
American Gastroenterological Association Annual Meeting. Orlando, FL
Gender differences and response to radiofrequency ablation for Barrett’s esophagus: Results from the U.S. RFA Registry.
American Gastroenterological Association Annual Meeting. Orlando, FL
Join now to see all